Share
Capital

Contributed
Surplus

Cumulative
Translation
Adjustments

Deficit

Total

Balance at December 31, 2013

$

194,337

$

10,671

$

37

$

(199,352)

$

5,693

Comprehensive loss for the period

-

-

(94)

(12,800)

(12,894)

Share-based compensation

40

408

-

-

448

Issuance costs

-

(5)

-

-

(5)

Deferred tax effect of convertible note

-

(383)

-

-

(383)

Conversion option of convertible note

-

704

-

-

704

Balance at December 31, 2014

$

194,377

$

11,395

$

(57)

$

(212,152)

$

(6,437)

Comprehensive loss for the period

-

-

(45)

(18,154)

(18,199)

Share-based compensation

30

294

-

-

324

Exercise of warrants

1,004

-

-

-

1,004

Exercise of options

57

(22)

-

-

35

Note conversion

556

(16)

-

-

540

New warrant issuance

385

-

-

-

385

Deferred tax effect of convertible note

-

(73)

-

-

(73)

Balance at December 31, 2015

$

196,409

$

11,578

$

(102)

$

(230,306)

$

(22,421)

For the years ended December 31,

2015

2014

Cash flows provided by:

Operating activities:

Net loss for the period

$

(18,154)

$

(12,800)

Adjusted for the following non-cash items:

Depreciation of property and equipment

974

1,123

Amortization of intangible assets

13

103

Share-based compensation expense

638

454

Gain on disposal of equipment

(94)

(456)

Amortization of deferred lease inducements

(144)

(41)

Deferred taxes

(73)

(383)

Change in fair value of derivative instruments

2,572

(2,035)

Financing costs

6,661

2,006

Current income tax expense

27

-

Interest paid

(18)

(22)

Income tax paid

(24)

(10)

Changes in working capital:

Amounts receivable

(896)

5,008

Work in process and other assets

169

116

Accounts payable and accrued liabilities

73

(784)

Unearned revenue and deposits

16

341

Gain on foreign currency translation

37

(42)

(8,223)

(7,422)

Investing activities:

Purchase of property and equipment

(50)

(609)

Proceeds from sale of equipment

-

360

(50)

(249)

Financing activities:

Proceeds from convertible notes and notes payable

8,500

6,000

Issuance costs of convertible notes and notes payable

(99)

(158)

Proceeds from reimbursable project funding

93

130

Proceeds from exercise of warrants

156

-

Proceeds from exercise of options

35

-

Increase in restricted cash

(801)

-

Repayment of obligations under finance lease

(146)

(115)

Repayment of long-term debt and notes payable

-

(65)

7,738

5,792

Effect of foreign exchange on cash

(2)

(4)

Decrease in cash and cash equivalents

(537)

(1,883)

Cash and cash equivalents, beginning of period

537

2,420

$

-

$

537